These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 32323798)

  • 1. lncRNA TPTEP1 competitively sponges miR‑328‑5p to inhibit the proliferation of non‑small cell lung cancer cells.
    Cao F; Wang Z; Feng Y; Zhu H; Yang M; Zhang S; Wang X
    Oncol Rep; 2020 May; 43(5):1606-1618. PubMed ID: 32323798
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FOXD3-AS1 suppresses the progression of non-small cell lung cancer by regulating miR-150/SRCIN1axis.
    Ji T; Zhang Y; Wang Z; Hou Z; Gao X; Zhang X
    Cancer Biomark; 2020; 29(3):417-427. PubMed ID: 32924985
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long non‑coding RNA TP73‑AS1 accelerates the progression and cisplatin resistance of non‑small cell lung cancer by upregulating the expression of TRIM29 via competitively targeting microRNA‑34a‑5p.
    Luo S; Shen M; Chen H; Li W; Chen C
    Mol Med Rep; 2020 Nov; 22(5):3822-3832. PubMed ID: 32901838
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SRCIN1 Regulated by circCCDC66/miR-211 Is Upregulated and Promotes Cell Proliferation in Non-Small-Cell Lung Cancer.
    Hong W; Yu S; Zhuang Y; Zhang Q; Wang J; Gao X
    Biomed Res Int; 2020; 2020():5307641. PubMed ID: 32964035
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-510 Plays Oncogenic Roles in Non-Small Cell Lung Cancer by Directly Targeting SRC Kinase Signaling Inhibitor 1.
    Wu W; He L; Huang Y; Hou L; Zhang W; Zhang L; Wu C
    Oncol Res; 2019 Aug; 27(8):879-887. PubMed ID: 30982489
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The lncRNA MALAT1 contributes to non-small cell lung cancer development via modulating miR-124/STAT3 axis.
    Li S; Mei Z; Hu HB; Zhang X
    J Cell Physiol; 2018 Sep; 233(9):6679-6688. PubMed ID: 29215698
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LncRNA SNHG1 influences cell proliferation, migration, invasion, and apoptosis of non-small cell lung cancer cells via the miR-361-3p/FRAT1 axis.
    Li X; Zheng H
    Thorac Cancer; 2020 Feb; 11(2):295-304. PubMed ID: 31788970
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long Noncoding RNA LINC00460 Promotes the Gefitinib Resistance of Nonsmall Cell Lung Cancer Through Epidermal Growth Factor Receptor by Sponging miR-769-5p.
    Ma G; Zhu J; Liu F; Yang Y
    DNA Cell Biol; 2019 Feb; 38(2):176-183. PubMed ID: 30601026
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LncRNA PCGEM1 accelerates non-small cell lung cancer progression via sponging miR-433-3p to upregulate WTAP.
    Weng L; Qiu K; Gao W; Shi C; Shu F
    BMC Pulm Med; 2020 Aug; 20(1):213. PubMed ID: 32787827
    [TBL] [Abstract][Full Text] [Related]  

  • 10. lincRNA‑p21 inhibits the progression of non‑small cell lung cancer via targeting miR‑17‑5p.
    Ao X; Jiang M; Zhou J; Liang H; Xia H; Chen G
    Oncol Rep; 2019 Feb; 41(2):789-800. PubMed ID: 30535441
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LncRNA MAGI2-AS3 suppresses the proliferation and invasion of non-small cell lung carcinoma through miRNA-23a-3p/PTEN axis.
    Hao XZ; Yang K
    Eur Rev Med Pharmacol Sci; 2019 Sep; 23(17):7399-7407. PubMed ID: 31539127
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long non-coding RNA linc00673 regulated non-small cell lung cancer proliferation, migration, invasion and epithelial mesenchymal transition by sponging miR-150-5p.
    Lu W; Zhang H; Niu Y; Wu Y; Sun W; Li H; Kong J; Ding K; Shen HM; Wu H; Xia D; Wu Y
    Mol Cancer; 2017 Jul; 16(1):118. PubMed ID: 28697764
    [TBL] [Abstract][Full Text] [Related]  

  • 13. miR-211 promotes non-small cell lung cancer proliferation by targeting SRCIN1.
    Ye L; Wang H; Liu B
    Tumour Biol; 2016 Jan; 37(1):1151-7. PubMed ID: 26277787
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long non-coding RNA PRNCR1 modulates non-small cell lung cancer cell proliferation, apoptosis, migration, invasion, and EMT through PRNCR1/miR-126-5p/MTDH axis.
    Guo R; Hu T; Liu Y; He Y; Cao Y
    Biosci Rep; 2020 Jul; 40(7):. PubMed ID: 31912882
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpression of lncRNA EGFR‑AS1 is associated with a poor prognosis and promotes chemotherapy resistance in non‑small cell lung cancer.
    Xu YH; Tu JR; Zhao TT; Xie SG; Tang SB
    Int J Oncol; 2019 Jan; 54(1):295-305. PubMed ID: 30431074
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miR-150 promotes the proliferation and migration of lung cancer cells by targeting SRC kinase signalling inhibitor 1.
    Cao M; Hou D; Liang H; Gong F; Wang Y; Yan X; Jiang X; Wang C; Zhang J; Zen K; Zhang CY; Chen X
    Eur J Cancer; 2014 Mar; 50(5):1013-24. PubMed ID: 24456795
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LINC00324 affects non-small cell lung cancer cell proliferation and invasion through regulation of the miR-139-5p/IGF1R axis.
    Zhang M; Lin B; Liu Y; Huang T; Chen M; Lian D; Deng S; Zhuang C
    Mol Cell Biochem; 2020 Oct; 473(1-2):193-202. PubMed ID: 32734536
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LncRNA SNHG1 contributes to the cisplatin resistance and progression of NSCLC via miR-330-5p/DCLK1 axis.
    Ge P; Cao L; Zheng M; Yao Y; Wang W; Chen X
    Exp Mol Pathol; 2021 Jun; 120():104633. PubMed ID: 33753110
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long non‑coding RNA FEZF1‑AS1 facilitates non‑small cell lung cancer progression via the ITGA11/miR‑516b‑5p axis.
    Song H; Li H; Ding X; Li M; Shen H; Li Y; Zhang X; Xing L
    Int J Oncol; 2020 Dec; 57(6):1333-1347. PubMed ID: 33174014
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Knockdown of LncRNA PVT1 inhibits tumorigenesis in non-small-cell lung cancer by regulating miR-497 expression.
    Guo D; Wang Y; Ren K; Han X
    Exp Cell Res; 2018 Jan; 362(1):172-179. PubMed ID: 29133127
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.